[Glenhill Advisors, LLC th 600 Fifth Avenue, 11 New York, NY 10020 April 12, 2019 The Board of Directors China XD Plastics Company Limited No. 9 Dalian North Road, Haping Road Centralized Industrial Park Harbin Development Zone Heilongjiang Province P. R. China Dear Sirs, As you are aware, Glenhill A]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Companys announcement dated 27 August 2004. The accumulated premium inco]
[Number 99.1 Major Operating Data of the First Quarter of 2019. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Shi Wei]
[Registration No. 333-221868 PROSPECTUS SUPPLEMENT (to Prospectus dated December 8, 2017) 2,359,272 Shares of Common Stock Securities Act Our common stock is listed on the Nasdaq Capital Market and traded under the symbol “CREG.” The last reported sale price of our common stock on the Nasdaq Capital ]
[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 Peoples Republic of China Form 20-F x o o o Appointment of New Chief Technology Officer 2 Vipshop Holdings Limited]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
